Pharmacological strategies for treating social anxiety disorder in adults: a systematic review of studies published since 2015
When CBT is unavailable, SSRIs are the first-line pharmacological treatment for SAD based on current evidence. However, response rates vary substantially. We recommend a personalized approach that includes patient preference and treatment accessibility.
Authors
- Giovanbattista Andreoli (ORCID: https://orcid.org/0000-0003-1389-6515)
- Stefan G. Hofmann (ORCID: https://orcid.org/0000-0002-3548-9681)
- Cameron E Lindsay (ORCID: https://orcid.org/0009-0009-0253-0834)
- Chantal Kasch (ORCID: https://orcid.org/0009-0002-2840-1095)
Institutions
- Philipps University of Marburg (DE)
Publication Details
- Journal
- Expert Review of Neurotherapeutics
- Published
- 2025-12-13
- DOI
- https://doi.org/10.1080/14737175.2025.2604303
- Primary Topic
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Type
- article
- Field-Weighted Citation Impact
- 0.00